Cancer Epigenetics Institute, Fox Chase Cancer Center, Philadelphia, Pennsylvania; Nuclear Dynamics and Cancer Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Coriell Institute for Medical Research, Camden, New Jersey.
Gastroenterology. 2023 May;164(6):921-936.e1. doi: 10.1053/j.gastro.2023.01.039. Epub 2023 Feb 8.
BACKGROUND & AIMS: Aberrant DNA methylation is frequent in colorectal cancer (CRC), but underlying mechanisms and pathologic consequences are poorly understood.
We disrupted active DNA demethylation genes Tet1 and/or Tdg from Apc mice and characterized the methylome and transcriptome of colonic adenomas. Data were compared to human colonic adenocarcinomas (COAD) in The Cancer Genome Atlas.
There were increased numbers of small intestinal adenomas in Apc mice expressing the Tdg allele, whereas Tet1-deficient and Tet1/Tdg-double heterozygous Apc colonic adenomas were larger with features of erosion and invasion. We detected reduction in global DNA hypomethylation in colonic adenomas from Tet1- and Tdg-mutant Apc mice and hypermethylation of CpG islands in Tet1-mutant Apc adenomas. Up-regulation of inflammatory, immune, and interferon response genes was present in Tet1- and Tdg-mutant colonic adenomas compared to control Apc adenomas. This up-regulation was also seen in murine colonic organoids and human CRC lines infected with lentiviruses expressing TET1 or TDG short hairpin RNA. A 127-gene inflammatory signature separated colonic adenocarcinomas into 4 groups, closely aligned with their microsatellite or chromosomal instability and characterized by different levels of DNA methylation and DNMT1 expression that anticorrelated with TET1 expression. Tumors with the CpG island methylator phenotype (CIMP) had concerted high DNMT1/low TET1 expression. TET1 or TDG knockdown in CRC lines enhanced killing by natural killer cells.
Our findings reveal a novel epigenetic regulation, linked to the type of genomic instability, by which TET1/TDG-mediated DNA demethylation decreases methylation levels and inflammatory/interferon/immune responses. CIMP in CRC is triggered by an imbalance of methylating activities over demethylating activities. These mice represent a model of CIMP CRC.
结直肠癌(CRC)中经常出现异常的 DNA 甲基化,但潜在机制和病理后果仍知之甚少。
我们敲除了 Apc 小鼠中活性 DNA 去甲基化基因 Tet1 和/或 Tdg,并对结肠腺瘤的甲基组和转录组进行了特征分析。将数据与癌症基因组图谱(TCGA)中的人类结肠腺癌(COAD)进行了比较。
在表达 Tdg 等位基因的 Apc 小鼠中,小肠腺瘤的数量增加,而 Tet1 缺陷和 Tet1/Tdg 双杂合 Apc 结肠腺瘤则更大,具有侵蚀和侵袭的特征。我们在 Tet1-和 Tdg 突变 Apc 小鼠的结肠腺瘤中检测到全基因组 DNA 低甲基化减少,而在 Tet1 突变 Apc 腺瘤中 CpG 岛发生超甲基化。与对照 Apc 腺瘤相比,Tet1-和 Tdg 突变的结肠腺瘤中炎症、免疫和干扰素反应基因上调。这种上调也见于感染表达 TET1 或 TDG 短发夹 RNA 的慢病毒的鼠结肠类器官和人 CRC 系。一个由 127 个基因组成的炎症特征将结肠腺癌分为 4 组,与它们的微卫星或染色体不稳定性密切相关,并以不同水平的 DNA 甲基化和与 TET1 表达呈负相关的 DNMT1 表达为特征。具有 CpG 岛甲基化表型(CIMP)的肿瘤具有协同的高 DNMT1/低 TET1 表达。在 CRC 系中敲低 TET1 或 Tdg 可增强自然杀伤细胞的杀伤作用。
我们的研究结果揭示了一种新的表观遗传调控机制,与基因组不稳定性的类型相关,TET1/TDG 介导的 DNA 去甲基化降低了甲基化水平和炎症/干扰素/免疫反应。CRC 中的 CIMP 是由甲基化活性与去甲基化活性之间的失衡引发的。这些小鼠代表了 CIMP CRC 的模型。